Potential New Targets in Arthritis Therapy: Interleukin (IL)-17 and Its Relation to Tumour Necrosis Factor and IL-1 in Experimental Arthritis

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2006.058529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

IL-32 and IL-17 Interact and Have the Potential to Aggravate Osteoclastogenesis in Rheumatoid Arthritis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS

TURKISH MEDICAL STUDENT JOURNAL
2020English

Tumour Necrosis Factor Gene Polymorphisms in Egyptian Patients With Rheumatoid Arthritis and Their Relation to Disease Activity and Severity

Central-European Journal of Immunology
AllergyImmunology
2019English

A Mechanism of IL-17 Action in the Rheumatoid Arthritis

Ensho Saisei
2001English

IL-23 Induces Human Osteoclastogenesis via IL-17 in Vitro, and Anti-Il-23 Antibody Attenuates Collagen-Induced Arthritis in Rats

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2007English

Increased Interleukin-1 (IL-1) and Imbalance Between IL-1 and IL-1 Receptor Antagonist During Acute Inflammation in Experimental Shigellosis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1999English

IL-23 Dependent and Independent Stages of Experimental Arthritis: No Clinical Effect of Therapeutic IL-23p19 Inhibition in Collagen-Induced Arthritis

PLoS ONE
Multidisciplinary
2013English

Inhibition of Tumour Necrosis Factor and IL-17 Production by Leflunomide Involves the JAK/STAT Pathway

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

IL-17/IL-17 Receptor System in Autoimmune Disease: Mechanisms and Therapeutic Potential

Clinical Science
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy